Alchemy
San Francisco, USA· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
AI-driven platform for designing and optimizing small molecule therapeutics and advanced drug delivery systems.
OncologyNeurology
Technology Platform
AI and machine learning platform for de novo small molecule design and drug delivery system optimization, integrating computational modeling with experimental validation.
Opportunities
Potential to reduce drug development timelines and costs while improving therapeutic precision through AI-designed delivery mechanisms.
Risk Factors
Risk of AI predictions failing to translate into effective and safe therapies in biological systems.
Competitive Landscape
Competes with AI-driven drug discovery firms like Recursion and Exscientia, but focuses uniquely on integrating delivery optimization from the outset.